Merck Not Losing Sleep Over Vioxx Disaster

SAVE AS FAVORITE

VIEW FAVORITES

By Evelyn Pringle (about the author) Page 7 of 7 page(s)

opednews.com Permalink

For instance, in March 2005, a class action lawsuit was filed in the US District Court for the District of Massachusetts, on behalf of shareholders in Elan Corp PLC, after the company's withdrawal of the multiple sclerosis drug Tysabri, with many of the same allegations that can be made against Merck.

The complaint alleges that Elan failed to disclose and misrepresented material adverse facts in connection with Tysabri including serious immune-system side effects and that the information was concealed in order to fast track Tysabri for FDA approval.

In any event, notwithstanding that Merck continues to contend that it will try every single case, legal analysts say, state courts will never be able to handle the trials for the lawsuits already filed, much less the additional cases still being filed on a regular basis.

"At some point courts are going to be clogged with these cases and judges will start to put pressure on Merck and the plaintiffs to settle these cases," according to John Leubsdorf, professor of law at Rutgers Law School, on CNN Moneyline on April 26, 2006.

"The only scenario in which they won't settle," he says, "is if they win so much that all the plaintiffs go away."

But legal experts say, that is definitely not going to happen.

Information for injured parties can be found at Lawyers and Settlements.com

http://www.lawyersandsettlements.com/articles/merck_vioxx_lawsuit.html

Evelyn Pringle
evelyn.pringle@sbcglobal.net

1 | 2 | 3 | 4 | 5 | 6 | 7

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author

Contact Editor

View Authors' Articles

Book Recommendations for "Australia Canada Corporate"

A comparative study of the contents of corporate codes of ethics in Australia, Canada and Sweden [An article from: Journal of World Business]
by J. Singh

$10.95

Number of pages:
Publisher: Elsevier

2007 Corporate Social Responsibility: United States, Australia, India, China, Canada, Mexico and Brazil: A Pilot Study (Shrm Research)
by Society for Human Resource Management

$99.95
Lowest New Price $99.94
Number of pages: 40
Publisher: Society For Human Resource Management

Current Developments in International and Comparative Corporate Insolvency Law

$365.00
Lowest New Price $266.45
Number of pages: 848
Publisher: Oxford University Press, USA